Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
RayzeBio, Inc.
Vanquish Oncology, Inc.
Dana-Farber Cancer Institute
University of Iowa
Novartis